SCHEMBL21035639

SCHEMBL21035639

Fc1ccc(-c2ccc(CCl)cn2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 4/20 0.54
CYP11B2 P19099 4/20 0.54
MET P08581 3/20 0.54
AURKA O14965 1/20 0.54
ABL1 P00519 1/20 0.54
NTRK1 P04629 1/20 0.54
LCK P06239 1/20 0.54
CSF1R P07333 1/20 0.54
RET P07949 1/20 0.54
PDGFRB P09619 1/20 0.54
PIM1 P11309 1/20 0.54
PDGFRA P16234 1/20 0.54
FLT3 P36888 1/20 0.54
MAPK8 P45983 1/20 0.54
CDK8 P49336 1/20 0.54
MAP2K1 Q02750 1/20 0.54
MAP4K2 Q12851 1/20 0.54
ROCK1 Q13464 1/20 0.54
NTRK3 Q16288 1/20 0.54
MAPK14 Q16539 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17610081 0.89 CYP11B1 (0.47) CYP11B1CYP11B2METAURKAABL1
SCHEMBL1549465 0.83 GRM2 (0.50) CYP11B1CYP11B2NPC1RAB9ASMN1; SMN2
SCHEMBL9602018 0.81 NPC1 (0.61) CYP11B1CYP11B2METAURKAABL1
SCHEMBL26316731 0.81 AURKA (0.54) CYP11B1CYP11B2METAURKAABL1
SCHEMBL2216313 0.81 FYN (0.56) CYP11B1CYP11B2METAURKAABL1
SCHEMBL317352 0.81 CYP11B1 (0.54) CYP11B1CYP11B2METAURKAABL1
SCHEMBL317351 0.81 CYP11B1 (0.54) CYP11B1CYP11B2METAURKAABL1
SCHEMBL2411349 0.81 CYP11B1 (0.59) CYP11B1CYP11B2NPC1RAB9ASMN1; SMN2
SCHEMBL8382983 0.81 CYP11B1 (0.57) CYP11B1CYP11B2METAURKAABL1
SCHEMBL1550000 0.81 CYP11B1 (0.49) CYP11B1CYP11B2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed